Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000294400 is a predicted non-coding transcript antisense to PTRF, lacking evidence for protein-coding function or validated therapeutic relevance. It is annotated as a non-coding RNA that is transcribed from a locus opposite to the Polymerase I and transcript release factor (PTRF/CAVIN1) gene. There is currently no evidence that this transcript encodes a protein or functions as a typical therapeutic target. Its biological function and role in disease—if any—remain unknown or uncharacterized. No interactions with drugs, known mechanism of action, biomarkers, or safety concerns are reported. This type of annotation typically arises from transcriptomics pipelines identifying non-coding RNAs or speculative transcripts, and such entries may be subject to change or removal as annotation databases are updated. It is not considered a validated or actionable biomedical target, and the entry may reflect a provisional, computationally predicted, or low-confidence transcript model. This entity is not synonymous with PTRF/CAVIN1; it is annotated as a "novel" antisense transcript, not the well-characterized PTRF gene itself. As it is neither a protein-coding gene nor a functionally validated non-coding RNA, it is not considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, antisense to Polymerase I and transcript release factor.